MYL9
protein-codingmyosin light chain 9, the group of Myosin light chains, class 2
Gene summary
Myosin, a structural component of muscle, consists of two heavy chains and four light chains. The protein encoded by this gene is a myosin light chain that may regulate muscle contraction by modulating the ATPase activity of myosin heads. The encoded protein binds calcium and is activated by myosin light chain kinase. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~10.0 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030296
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0030296
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0030296
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Gastrointestinal; Genitourinary; Musculoskeletal; Ophthalmologic; Renal
Intervention: Gastrointestinal; Renal
Rationale: Individuals have been described as benefiting from surgical interventions, including related to renal anomalies and nephrolithiasis; Multivisceral transplantation has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYL9 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006097.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 21 | 21 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 2 | 2 | 4 | |||
| Total | 0 | 2 | 24 | 1 | 0 | 27 |
Highest pathogenic variant AF is 0.000008210866
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006088.2 | 3 | MANE Select | |
| Ensembl | ENSP00000279022.2 | 3 | MANE Select | |
| RefSeq | NP_852667.1 | 2 | Standard | |
| Ensembl | ENSP00000217313.2 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Focal adhesion - Homo sapiens (human)
- Oxytocin signaling pathway - Homo sapiens (human)
- Tight junction - Homo sapiens (human)
- Regulation of actin cytoskeleton - Homo sapiens (human)
- cAMP signaling pathway - Homo sapiens (human)
Biological Process
- muscle contraction
- regulation of muscle contraction
- regulation of megakaryocyte differentiation
- platelet aggregation
Molecular Function
- calcium ion binding
- structural constituent of muscle
- myosin heavy chain binding
Cellular Component
- stress fiber
- cytosol
- muscle myosin complex
- Z disc
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000279022
- Coding exons
- 3
- Length
- 8342
- Individuals with no LoFs
- 125728
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 18
- Defined
- 125746
- p
- 0.0000716
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.17 | 83 | 119 | 0.698 | 0.00000773 | 1176 |
| Missense (PolyPhen) | 17 | 30.866 | 0.55077 | 364 | ||
| Synonymous | 0.375 | 43 | 46.2 | 0.930 | 0.00000332 | 301 |
| Loss of Function | 0.841 | 3 | 5.04 | 0.596 | 2.13e-7 | 63 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00028 | 0.00027 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000071 | 0.000070 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion. {ECO:0000269|PubMed:11942626, ECO:0000269|PubMed:2526655}.;
Recessive Scores
- pRec
- 0.149
Intolerance Scores
- LoFtool
- 0.626
- RVIS EVS
- -0.16
- RVIS percentile EVS
- 41.25
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.982
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |